nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—CYP2D6—Gefitinib—lung cancer	0.0514	0.108	CbGbCtD
Rotigotine—CYP2D6—Vinorelbine—lung cancer	0.0396	0.0832	CbGbCtD
Rotigotine—CYP1A2—Erlotinib—lung cancer	0.0369	0.0775	CbGbCtD
Rotigotine—CYP3A4—Topotecan—lung cancer	0.0357	0.0751	CbGbCtD
Rotigotine—CYP3A4—Gefitinib—lung cancer	0.0327	0.0687	CbGbCtD
Rotigotine—CYP3A4—Teniposide—lung cancer	0.0317	0.0666	CbGbCtD
Rotigotine—CYP2D6—Erlotinib—lung cancer	0.0304	0.0639	CbGbCtD
Rotigotine—CYP1A2—Etoposide—lung cancer	0.0267	0.0561	CbGbCtD
Rotigotine—CYP3A4—Vinorelbine—lung cancer	0.0252	0.0529	CbGbCtD
Rotigotine—CYP2D6—Vinblastine—lung cancer	0.0244	0.0513	CbGbCtD
Rotigotine—CYP3A4—Crizotinib—lung cancer	0.02	0.0421	CbGbCtD
Rotigotine—CYP3A4—Erlotinib—lung cancer	0.0193	0.0406	CbGbCtD
Rotigotine—CYP3A4—Paclitaxel—lung cancer	0.0177	0.0372	CbGbCtD
Rotigotine—CYP3A4—Irinotecan—lung cancer	0.0174	0.0367	CbGbCtD
Rotigotine—CYP3A4—Vinblastine—lung cancer	0.0155	0.0326	CbGbCtD
Rotigotine—CYP2D6—Doxorubicin—lung cancer	0.015	0.0315	CbGbCtD
Rotigotine—CYP3A4—Etoposide—lung cancer	0.014	0.0294	CbGbCtD
Rotigotine—CYP3A4—Docetaxel—lung cancer	0.0128	0.0269	CbGbCtD
Rotigotine—CYP3A4—Doxorubicin—lung cancer	0.00953	0.02	CbGbCtD
Rotigotine—Decreased appetite—Gemcitabine—lung cancer	0.000291	0.000801	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.00029	0.0008	CcSEcCtD
Rotigotine—Nausea—Topotecan—lung cancer	0.000289	0.000797	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000289	0.000796	CcSEcCtD
Rotigotine—Discomfort—Paclitaxel—lung cancer	0.000289	0.000795	CcSEcCtD
Rotigotine—Fatigue—Gemcitabine—lung cancer	0.000288	0.000795	CcSEcCtD
Rotigotine—Confusional state—Etoposide—lung cancer	0.000288	0.000794	CcSEcCtD
Rotigotine—Pain—Gemcitabine—lung cancer	0.000286	0.000788	CcSEcCtD
Rotigotine—Constipation—Gemcitabine—lung cancer	0.000286	0.000788	CcSEcCtD
Rotigotine—Nausea—Erlotinib—lung cancer	0.000286	0.000788	CcSEcCtD
Rotigotine—Dry mouth—Paclitaxel—lung cancer	0.000286	0.000787	CcSEcCtD
Rotigotine—Diarrhoea—Vinorelbine—lung cancer	0.000285	0.000785	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000284	0.000783	CcSEcCtD
Rotigotine—Infection—Etoposide—lung cancer	0.000284	0.000782	CcSEcCtD
Rotigotine—Feeling abnormal—Irinotecan—lung cancer	0.000283	0.00078	CcSEcCtD
Rotigotine—Confusional state—Paclitaxel—lung cancer	0.000282	0.000778	CcSEcCtD
Rotigotine—Paraesthesia—Cisplatin—lung cancer	0.00028	0.000772	CcSEcCtD
Rotigotine—Muscle spasms—Docetaxel—lung cancer	0.00028	0.000771	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Methotrexate—lung cancer	0.00028	0.000771	CcSEcCtD
Rotigotine—Infection—Paclitaxel—lung cancer	0.000278	0.000767	CcSEcCtD
Rotigotine—Skin disorder—Etoposide—lung cancer	0.000277	0.000765	CcSEcCtD
Rotigotine—Erectile dysfunction—Methotrexate—lung cancer	0.000277	0.000764	CcSEcCtD
Rotigotine—Hyperhidrosis—Etoposide—lung cancer	0.000276	0.000761	CcSEcCtD
Rotigotine—Feeling abnormal—Gemcitabine—lung cancer	0.000276	0.00076	CcSEcCtD
Rotigotine—Shock—Paclitaxel—lung cancer	0.000276	0.000759	CcSEcCtD
Rotigotine—Dizziness—Vinorelbine—lung cancer	0.000275	0.000759	CcSEcCtD
Rotigotine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000275	0.000759	CcSEcCtD
Rotigotine—Nervous system disorder—Paclitaxel—lung cancer	0.000275	0.000757	CcSEcCtD
Rotigotine—Breast disorder—Doxorubicin—lung cancer	0.000272	0.000751	CcSEcCtD
Rotigotine—Anorexia—Etoposide—lung cancer	0.000272	0.00075	CcSEcCtD
Rotigotine—Skin disorder—Paclitaxel—lung cancer	0.000272	0.00075	CcSEcCtD
Rotigotine—Decreased appetite—Cisplatin—lung cancer	0.000271	0.000747	CcSEcCtD
Rotigotine—Hyperhidrosis—Paclitaxel—lung cancer	0.000271	0.000746	CcSEcCtD
Rotigotine—Nasopharyngitis—Doxorubicin—lung cancer	0.00027	0.000743	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000269	0.000742	CcSEcCtD
Rotigotine—Infestation NOS—Methotrexate—lung cancer	0.000268	0.000739	CcSEcCtD
Rotigotine—Infestation—Methotrexate—lung cancer	0.000268	0.000739	CcSEcCtD
Rotigotine—Depression—Methotrexate—lung cancer	0.000268	0.000737	CcSEcCtD
Rotigotine—Anorexia—Paclitaxel—lung cancer	0.000267	0.000736	CcSEcCtD
Rotigotine—Hypotension—Etoposide—lung cancer	0.000267	0.000736	CcSEcCtD
Rotigotine—Pain—Cisplatin—lung cancer	0.000267	0.000735	CcSEcCtD
Rotigotine—Vomiting—Vinorelbine—lung cancer	0.000265	0.00073	CcSEcCtD
Rotigotine—Rash—Vinorelbine—lung cancer	0.000263	0.000724	CcSEcCtD
Rotigotine—Dermatitis—Vinorelbine—lung cancer	0.000262	0.000723	CcSEcCtD
Rotigotine—Hypotension—Paclitaxel—lung cancer	0.000262	0.000721	CcSEcCtD
Rotigotine—Headache—Vinorelbine—lung cancer	0.000261	0.000719	CcSEcCtD
Rotigotine—Syncope—Docetaxel—lung cancer	0.000261	0.000719	CcSEcCtD
Rotigotine—Feeling abnormal—Cisplatin—lung cancer	0.000257	0.000708	CcSEcCtD
Rotigotine—Paraesthesia—Etoposide—lung cancer	0.000257	0.000707	CcSEcCtD
Rotigotine—Loss of consciousness—Docetaxel—lung cancer	0.000256	0.000705	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000255	0.000703	CcSEcCtD
Rotigotine—Somnolence—Etoposide—lung cancer	0.000254	0.0007	CcSEcCtD
Rotigotine—Cough—Docetaxel—lung cancer	0.000254	0.000699	CcSEcCtD
Rotigotine—Insomnia—Paclitaxel—lung cancer	0.000253	0.000698	CcSEcCtD
Rotigotine—Hypersensitivity—Irinotecan—lung cancer	0.000253	0.000697	CcSEcCtD
Rotigotine—Paraesthesia—Paclitaxel—lung cancer	0.000252	0.000693	CcSEcCtD
Rotigotine—Hypertension—Docetaxel—lung cancer	0.000251	0.000692	CcSEcCtD
Rotigotine—Somnolence—Paclitaxel—lung cancer	0.000249	0.000686	CcSEcCtD
Rotigotine—Decreased appetite—Etoposide—lung cancer	0.000248	0.000684	CcSEcCtD
Rotigotine—Arthralgia—Docetaxel—lung cancer	0.000248	0.000682	CcSEcCtD
Rotigotine—Nausea—Vinorelbine—lung cancer	0.000247	0.000682	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Etoposide—lung cancer	0.000247	0.00068	CcSEcCtD
Rotigotine—Dyspepsia—Paclitaxel—lung cancer	0.000247	0.000679	CcSEcCtD
Rotigotine—Asthenia—Irinotecan—lung cancer	0.000246	0.000679	CcSEcCtD
Rotigotine—Fatigue—Etoposide—lung cancer	0.000246	0.000679	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000246	0.000678	CcSEcCtD
Rotigotine—Pain—Etoposide—lung cancer	0.000244	0.000673	CcSEcCtD
Rotigotine—Constipation—Etoposide—lung cancer	0.000244	0.000673	CcSEcCtD
Rotigotine—Decreased appetite—Paclitaxel—lung cancer	0.000243	0.000671	CcSEcCtD
Rotigotine—Dry mouth—Docetaxel—lung cancer	0.000242	0.000667	CcSEcCtD
Rotigotine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000242	0.000667	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000242	0.000666	CcSEcCtD
Rotigotine—Fatigue—Paclitaxel—lung cancer	0.000241	0.000665	CcSEcCtD
Rotigotine—Asthenia—Gemcitabine—lung cancer	0.00024	0.000661	CcSEcCtD
Rotigotine—Constipation—Paclitaxel—lung cancer	0.00024	0.00066	CcSEcCtD
Rotigotine—Pain—Paclitaxel—lung cancer	0.00024	0.00066	CcSEcCtD
Rotigotine—Confusional state—Docetaxel—lung cancer	0.000239	0.00066	CcSEcCtD
Rotigotine—Weight increased—Doxorubicin—lung cancer	0.000237	0.000653	CcSEcCtD
Rotigotine—Pruritus—Gemcitabine—lung cancer	0.000237	0.000652	CcSEcCtD
Rotigotine—Infection—Docetaxel—lung cancer	0.000236	0.00065	CcSEcCtD
Rotigotine—Weight decreased—Doxorubicin—lung cancer	0.000236	0.00065	CcSEcCtD
Rotigotine—Feeling abnormal—Etoposide—lung cancer	0.000235	0.000649	CcSEcCtD
Rotigotine—Diarrhoea—Irinotecan—lung cancer	0.000235	0.000648	CcSEcCtD
Rotigotine—Shock—Docetaxel—lung cancer	0.000234	0.000644	CcSEcCtD
Rotigotine—Nervous system disorder—Docetaxel—lung cancer	0.000233	0.000642	CcSEcCtD
Rotigotine—Infestation NOS—Doxorubicin—lung cancer	0.000232	0.00064	CcSEcCtD
Rotigotine—Infestation—Doxorubicin—lung cancer	0.000232	0.00064	CcSEcCtD
Rotigotine—Visual impairment—Methotrexate—lung cancer	0.000232	0.00064	CcSEcCtD
Rotigotine—Feeling abnormal—Paclitaxel—lung cancer	0.000231	0.000636	CcSEcCtD
Rotigotine—Skin disorder—Docetaxel—lung cancer	0.000231	0.000635	CcSEcCtD
Rotigotine—Hypersensitivity—Cisplatin—lung cancer	0.00023	0.000633	CcSEcCtD
Rotigotine—Diarrhoea—Gemcitabine—lung cancer	0.000229	0.000631	CcSEcCtD
Rotigotine—Dizziness—Irinotecan—lung cancer	0.000227	0.000626	CcSEcCtD
Rotigotine—Urticaria—Etoposide—lung cancer	0.000227	0.000625	CcSEcCtD
Rotigotine—Anorexia—Docetaxel—lung cancer	0.000226	0.000624	CcSEcCtD
Rotigotine—Tinnitus—Methotrexate—lung cancer	0.000225	0.000619	CcSEcCtD
Rotigotine—Asthenia—Cisplatin—lung cancer	0.000224	0.000616	CcSEcCtD
Rotigotine—Urticaria—Paclitaxel—lung cancer	0.000223	0.000613	CcSEcCtD
Rotigotine—Hypotension—Docetaxel—lung cancer	0.000222	0.000611	CcSEcCtD
Rotigotine—Angiopathy—Methotrexate—lung cancer	0.000219	0.000602	CcSEcCtD
Rotigotine—Vomiting—Irinotecan—lung cancer	0.000218	0.000602	CcSEcCtD
Rotigotine—Sinusitis—Doxorubicin—lung cancer	0.000218	0.000601	CcSEcCtD
Rotigotine—Immune system disorder—Methotrexate—lung cancer	0.000218	0.000599	CcSEcCtD
Rotigotine—Mediastinal disorder—Methotrexate—lung cancer	0.000217	0.000598	CcSEcCtD
Rotigotine—Rash—Irinotecan—lung cancer	0.000217	0.000597	CcSEcCtD
Rotigotine—Dermatitis—Irinotecan—lung cancer	0.000216	0.000596	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000216	0.000596	CcSEcCtD
Rotigotine—Headache—Irinotecan—lung cancer	0.000215	0.000593	CcSEcCtD
Rotigotine—Insomnia—Docetaxel—lung cancer	0.000215	0.000592	CcSEcCtD
Rotigotine—Diarrhoea—Cisplatin—lung cancer	0.000213	0.000588	CcSEcCtD
Rotigotine—Paraesthesia—Docetaxel—lung cancer	0.000213	0.000587	CcSEcCtD
Rotigotine—Vomiting—Gemcitabine—lung cancer	0.000213	0.000586	CcSEcCtD
Rotigotine—Somnolence—Docetaxel—lung cancer	0.000211	0.000582	CcSEcCtD
Rotigotine—Mental disorder—Methotrexate—lung cancer	0.000211	0.000581	CcSEcCtD
Rotigotine—Rash—Gemcitabine—lung cancer	0.000211	0.000581	CcSEcCtD
Rotigotine—Dermatitis—Gemcitabine—lung cancer	0.000211	0.000581	CcSEcCtD
Rotigotine—Hypersensitivity—Etoposide—lung cancer	0.00021	0.00058	CcSEcCtD
Rotigotine—Malnutrition—Methotrexate—lung cancer	0.00021	0.000578	CcSEcCtD
Rotigotine—Erythema—Methotrexate—lung cancer	0.00021	0.000578	CcSEcCtD
Rotigotine—Headache—Gemcitabine—lung cancer	0.00021	0.000578	CcSEcCtD
Rotigotine—Dyspepsia—Docetaxel—lung cancer	0.000209	0.000576	CcSEcCtD
Rotigotine—Decreased appetite—Docetaxel—lung cancer	0.000206	0.000569	CcSEcCtD
Rotigotine—Hypersensitivity—Paclitaxel—lung cancer	0.000206	0.000569	CcSEcCtD
Rotigotine—Oedema peripheral—Doxorubicin—lung cancer	0.000205	0.000566	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000205	0.000565	CcSEcCtD
Rotigotine—Asthenia—Etoposide—lung cancer	0.000205	0.000565	CcSEcCtD
Rotigotine—Connective tissue disorder—Doxorubicin—lung cancer	0.000205	0.000565	CcSEcCtD
Rotigotine—Fatigue—Docetaxel—lung cancer	0.000205	0.000564	CcSEcCtD
Rotigotine—Nausea—Irinotecan—lung cancer	0.000204	0.000562	CcSEcCtD
Rotigotine—Pain—Docetaxel—lung cancer	0.000203	0.000559	CcSEcCtD
Rotigotine—Constipation—Docetaxel—lung cancer	0.000203	0.000559	CcSEcCtD
Rotigotine—Pruritus—Etoposide—lung cancer	0.000202	0.000557	CcSEcCtD
Rotigotine—Visual impairment—Doxorubicin—lung cancer	0.000201	0.000554	CcSEcCtD
Rotigotine—Asthenia—Paclitaxel—lung cancer	0.000201	0.000554	CcSEcCtD
Rotigotine—Nausea—Gemcitabine—lung cancer	0.000199	0.000548	CcSEcCtD
Rotigotine—Vomiting—Cisplatin—lung cancer	0.000198	0.000546	CcSEcCtD
Rotigotine—Pruritus—Paclitaxel—lung cancer	0.000198	0.000546	CcSEcCtD
Rotigotine—Rash—Cisplatin—lung cancer	0.000197	0.000542	CcSEcCtD
Rotigotine—Dermatitis—Cisplatin—lung cancer	0.000196	0.000541	CcSEcCtD
Rotigotine—Feeling abnormal—Docetaxel—lung cancer	0.000196	0.000539	CcSEcCtD
Rotigotine—Diarrhoea—Etoposide—lung cancer	0.000195	0.000539	CcSEcCtD
Rotigotine—Ill-defined disorder—Methotrexate—lung cancer	0.000195	0.000536	CcSEcCtD
Rotigotine—Tinnitus—Doxorubicin—lung cancer	0.000194	0.000536	CcSEcCtD
Rotigotine—Diarrhoea—Paclitaxel—lung cancer	0.000192	0.000528	CcSEcCtD
Rotigotine—Angiopathy—Doxorubicin—lung cancer	0.000189	0.000521	CcSEcCtD
Rotigotine—Malaise—Methotrexate—lung cancer	0.000189	0.000521	CcSEcCtD
Rotigotine—Dizziness—Etoposide—lung cancer	0.000189	0.000521	CcSEcCtD
Rotigotine—Immune system disorder—Doxorubicin—lung cancer	0.000188	0.000519	CcSEcCtD
Rotigotine—Vertigo—Methotrexate—lung cancer	0.000188	0.000519	CcSEcCtD
Rotigotine—Mediastinal disorder—Doxorubicin—lung cancer	0.000188	0.000518	CcSEcCtD
Rotigotine—Dizziness—Paclitaxel—lung cancer	0.000185	0.00051	CcSEcCtD
Rotigotine—Nausea—Cisplatin—lung cancer	0.000185	0.00051	CcSEcCtD
Rotigotine—Cough—Methotrexate—lung cancer	0.000183	0.000504	CcSEcCtD
Rotigotine—Mental disorder—Doxorubicin—lung cancer	0.000183	0.000503	CcSEcCtD
Rotigotine—Vomiting—Etoposide—lung cancer	0.000182	0.000501	CcSEcCtD
Rotigotine—Malnutrition—Doxorubicin—lung cancer	0.000182	0.0005	CcSEcCtD
Rotigotine—Erythema—Doxorubicin—lung cancer	0.000182	0.0005	CcSEcCtD
Rotigotine—Rash—Etoposide—lung cancer	0.00018	0.000496	CcSEcCtD
Rotigotine—Dermatitis—Etoposide—lung cancer	0.00018	0.000496	CcSEcCtD
Rotigotine—Headache—Etoposide—lung cancer	0.000179	0.000493	CcSEcCtD
Rotigotine—Arthralgia—Methotrexate—lung cancer	0.000178	0.000492	CcSEcCtD
Rotigotine—Vomiting—Paclitaxel—lung cancer	0.000178	0.000491	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000177	0.000488	CcSEcCtD
Rotigotine—Rash—Paclitaxel—lung cancer	0.000177	0.000487	CcSEcCtD
Rotigotine—Dermatitis—Paclitaxel—lung cancer	0.000176	0.000486	CcSEcCtD
Rotigotine—Discomfort—Methotrexate—lung cancer	0.000176	0.000486	CcSEcCtD
Rotigotine—Headache—Paclitaxel—lung cancer	0.000175	0.000484	CcSEcCtD
Rotigotine—Hypersensitivity—Docetaxel—lung cancer	0.000175	0.000482	CcSEcCtD
Rotigotine—Muscle spasms—Doxorubicin—lung cancer	0.000175	0.000481	CcSEcCtD
Rotigotine—Confusional state—Methotrexate—lung cancer	0.000173	0.000475	CcSEcCtD
Rotigotine—Asthenia—Docetaxel—lung cancer	0.00017	0.000469	CcSEcCtD
Rotigotine—Infection—Methotrexate—lung cancer	0.00017	0.000468	CcSEcCtD
Rotigotine—Nausea—Etoposide—lung cancer	0.00017	0.000468	CcSEcCtD
Rotigotine—Ill-defined disorder—Doxorubicin—lung cancer	0.000168	0.000464	CcSEcCtD
Rotigotine—Pruritus—Docetaxel—lung cancer	0.000168	0.000463	CcSEcCtD
Rotigotine—Nervous system disorder—Methotrexate—lung cancer	0.000168	0.000462	CcSEcCtD
Rotigotine—Agitation—Doxorubicin—lung cancer	0.000167	0.00046	CcSEcCtD
Rotigotine—Nausea—Paclitaxel—lung cancer	0.000166	0.000458	CcSEcCtD
Rotigotine—Skin disorder—Methotrexate—lung cancer	0.000166	0.000458	CcSEcCtD
Rotigotine—Hyperhidrosis—Methotrexate—lung cancer	0.000165	0.000456	CcSEcCtD
Rotigotine—Malaise—Doxorubicin—lung cancer	0.000164	0.000451	CcSEcCtD
Rotigotine—Vertigo—Doxorubicin—lung cancer	0.000163	0.000449	CcSEcCtD
Rotigotine—Anorexia—Methotrexate—lung cancer	0.000163	0.000449	CcSEcCtD
Rotigotine—Syncope—Doxorubicin—lung cancer	0.000163	0.000449	CcSEcCtD
Rotigotine—Diarrhoea—Docetaxel—lung cancer	0.000162	0.000448	CcSEcCtD
Rotigotine—Hypotension—Methotrexate—lung cancer	0.00016	0.000441	CcSEcCtD
Rotigotine—Loss of consciousness—Doxorubicin—lung cancer	0.00016	0.00044	CcSEcCtD
Rotigotine—Cough—Doxorubicin—lung cancer	0.000158	0.000437	CcSEcCtD
Rotigotine—Dizziness—Docetaxel—lung cancer	0.000157	0.000433	CcSEcCtD
Rotigotine—Hypertension—Doxorubicin—lung cancer	0.000157	0.000432	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000156	0.00043	CcSEcCtD
Rotigotine—Insomnia—Methotrexate—lung cancer	0.000155	0.000426	CcSEcCtD
Rotigotine—Arthralgia—Doxorubicin—lung cancer	0.000155	0.000426	CcSEcCtD
Rotigotine—Paraesthesia—Methotrexate—lung cancer	0.000154	0.000423	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000153	0.000423	CcSEcCtD
Rotigotine—Discomfort—Doxorubicin—lung cancer	0.000153	0.000421	CcSEcCtD
Rotigotine—Somnolence—Methotrexate—lung cancer	0.000152	0.000419	CcSEcCtD
Rotigotine—Dry mouth—Doxorubicin—lung cancer	0.000151	0.000417	CcSEcCtD
Rotigotine—Vomiting—Docetaxel—lung cancer	0.000151	0.000416	CcSEcCtD
Rotigotine—Dyspepsia—Methotrexate—lung cancer	0.000151	0.000415	CcSEcCtD
Rotigotine—Rash—Docetaxel—lung cancer	0.00015	0.000412	CcSEcCtD
Rotigotine—Dermatitis—Docetaxel—lung cancer	0.00015	0.000412	CcSEcCtD
Rotigotine—Confusional state—Doxorubicin—lung cancer	0.000149	0.000412	CcSEcCtD
Rotigotine—Decreased appetite—Methotrexate—lung cancer	0.000149	0.00041	CcSEcCtD
Rotigotine—Headache—Docetaxel—lung cancer	0.000149	0.00041	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000148	0.000407	CcSEcCtD
Rotigotine—Fatigue—Methotrexate—lung cancer	0.000148	0.000407	CcSEcCtD
Rotigotine—Infection—Doxorubicin—lung cancer	0.000147	0.000406	CcSEcCtD
Rotigotine—Pain—Methotrexate—lung cancer	0.000146	0.000403	CcSEcCtD
Rotigotine—Shock—Doxorubicin—lung cancer	0.000146	0.000402	CcSEcCtD
Rotigotine—Nervous system disorder—Doxorubicin—lung cancer	0.000145	0.0004	CcSEcCtD
Rotigotine—Skin disorder—Doxorubicin—lung cancer	0.000144	0.000397	CcSEcCtD
Rotigotine—Hyperhidrosis—Doxorubicin—lung cancer	0.000143	0.000395	CcSEcCtD
Rotigotine—Anorexia—Doxorubicin—lung cancer	0.000141	0.000389	CcSEcCtD
Rotigotine—Nausea—Docetaxel—lung cancer	0.000141	0.000389	CcSEcCtD
Rotigotine—Feeling abnormal—Methotrexate—lung cancer	0.000141	0.000389	CcSEcCtD
Rotigotine—Hypotension—Doxorubicin—lung cancer	0.000138	0.000382	CcSEcCtD
Rotigotine—Urticaria—Methotrexate—lung cancer	0.000136	0.000375	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000135	0.000372	CcSEcCtD
Rotigotine—Insomnia—Doxorubicin—lung cancer	0.000134	0.000369	CcSEcCtD
Rotigotine—Paraesthesia—Doxorubicin—lung cancer	0.000133	0.000367	CcSEcCtD
Rotigotine—Somnolence—Doxorubicin—lung cancer	0.000132	0.000363	CcSEcCtD
Rotigotine—Dyspepsia—Doxorubicin—lung cancer	0.00013	0.000359	CcSEcCtD
Rotigotine—Decreased appetite—Doxorubicin—lung cancer	0.000129	0.000355	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000128	0.000352	CcSEcCtD
Rotigotine—Fatigue—Doxorubicin—lung cancer	0.000128	0.000352	CcSEcCtD
Rotigotine—Pain—Doxorubicin—lung cancer	0.000127	0.000349	CcSEcCtD
Rotigotine—Constipation—Doxorubicin—lung cancer	0.000127	0.000349	CcSEcCtD
Rotigotine—Hypersensitivity—Methotrexate—lung cancer	0.000126	0.000347	CcSEcCtD
Rotigotine—Asthenia—Methotrexate—lung cancer	0.000123	0.000338	CcSEcCtD
Rotigotine—Feeling abnormal—Doxorubicin—lung cancer	0.000122	0.000336	CcSEcCtD
Rotigotine—Pruritus—Methotrexate—lung cancer	0.000121	0.000334	CcSEcCtD
Rotigotine—Urticaria—Doxorubicin—lung cancer	0.000118	0.000324	CcSEcCtD
Rotigotine—Diarrhoea—Methotrexate—lung cancer	0.000117	0.000323	CcSEcCtD
Rotigotine—Dizziness—Methotrexate—lung cancer	0.000113	0.000312	CcSEcCtD
Rotigotine—Hypersensitivity—Doxorubicin—lung cancer	0.000109	0.000301	CcSEcCtD
Rotigotine—Vomiting—Methotrexate—lung cancer	0.000109	0.0003	CcSEcCtD
Rotigotine—Rash—Methotrexate—lung cancer	0.000108	0.000297	CcSEcCtD
Rotigotine—Dermatitis—Methotrexate—lung cancer	0.000108	0.000297	CcSEcCtD
Rotigotine—Headache—Methotrexate—lung cancer	0.000107	0.000295	CcSEcCtD
Rotigotine—Asthenia—Doxorubicin—lung cancer	0.000106	0.000293	CcSEcCtD
Rotigotine—Pruritus—Doxorubicin—lung cancer	0.000105	0.000289	CcSEcCtD
Rotigotine—Nausea—Methotrexate—lung cancer	0.000102	0.00028	CcSEcCtD
Rotigotine—Diarrhoea—Doxorubicin—lung cancer	0.000101	0.000279	CcSEcCtD
Rotigotine—Dizziness—Doxorubicin—lung cancer	9.8e-05	0.00027	CcSEcCtD
Rotigotine—Vomiting—Doxorubicin—lung cancer	9.42e-05	0.00026	CcSEcCtD
Rotigotine—Rash—Doxorubicin—lung cancer	9.34e-05	0.000257	CcSEcCtD
Rotigotine—Dermatitis—Doxorubicin—lung cancer	9.33e-05	0.000257	CcSEcCtD
Rotigotine—Headache—Doxorubicin—lung cancer	9.28e-05	0.000256	CcSEcCtD
Rotigotine—Nausea—Doxorubicin—lung cancer	8.8e-05	0.000243	CcSEcCtD
Rotigotine—DRD2—Signaling Pathways—EGF—lung cancer	1.24e-05	7.68e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.24e-05	7.68e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—KRAS—lung cancer	1.23e-05	7.62e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—lung cancer	1.23e-05	7.61e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CDKN1A—lung cancer	1.22e-05	7.59e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CXCL8—lung cancer	1.22e-05	7.58e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PTEN—lung cancer	1.22e-05	7.57e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRAS—lung cancer	1.21e-05	7.53e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCB1—lung cancer	1.21e-05	7.52e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTT1—lung cancer	1.21e-05	7.49e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CXCL8—lung cancer	1.21e-05	7.48e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—MAPK3—lung cancer	1.2e-05	7.44e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRAS—lung cancer	1.2e-05	7.43e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.19e-05	7.41e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GCLC—lung cancer	1.19e-05	7.41e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—POMC—lung cancer	1.19e-05	7.4e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TYMS—lung cancer	1.19e-05	7.39e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—lung cancer	1.19e-05	7.38e-05	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—lung cancer	1.18e-05	7.32e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—BRAF—lung cancer	1.18e-05	7.3e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GSTM1—lung cancer	1.18e-05	7.3e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—STK11—lung cancer	1.17e-05	7.27e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—lung cancer	1.17e-05	7.25e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—PIK3CA—lung cancer	1.17e-05	7.25e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL2—lung cancer	1.17e-05	7.24e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—PIK3CA—lung cancer	1.17e-05	7.24e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—lung cancer	1.16e-05	7.22e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MDM2—lung cancer	1.16e-05	7.22e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EP300—lung cancer	1.16e-05	7.22e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6R—lung cancer	1.16e-05	7.21e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—IL6—lung cancer	1.16e-05	7.21e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CREBBP—lung cancer	1.16e-05	7.2e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RAF1—lung cancer	1.16e-05	7.19e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—lung cancer	1.15e-05	7.16e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL2—lung cancer	1.15e-05	7.15e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ERBB2—lung cancer	1.15e-05	7.12e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—IL6—lung cancer	1.15e-05	7.11e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—EGFR—lung cancer	1.14e-05	7.08e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCND1—lung cancer	1.14e-05	7.06e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—JUN—lung cancer	1.14e-05	7.05e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MTOR—lung cancer	1.13e-05	7.02e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CB—lung cancer	1.13e-05	7.02e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ENO1—lung cancer	1.13e-05	7.02e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—lung cancer	1.13e-05	7.02e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—TP53—lung cancer	1.13e-05	7e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	1.13e-05	7e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MDM2—lung cancer	1.12e-05	6.97e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCND1—lung cancer	1.12e-05	6.97e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—JUN—lung cancer	1.12e-05	6.95e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RAF1—lung cancer	1.12e-05	6.95e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.12e-05	6.92e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAP2K1—lung cancer	1.11e-05	6.88e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ERBB2—lung cancer	1.11e-05	6.87e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ERCC2—lung cancer	1.11e-05	6.86e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—lung cancer	1.1e-05	6.85e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—lung cancer	1.1e-05	6.84e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CD—lung cancer	1.1e-05	6.83e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CDKN1A—lung cancer	1.1e-05	6.83e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.1e-05	6.83e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PTEN—lung cancer	1.1e-05	6.81e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MTOR—lung cancer	1.09e-05	6.78e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CB—lung cancer	1.09e-05	6.78e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STAT3—lung cancer	1.09e-05	6.77e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	1.09e-05	6.77e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—lung cancer	1.09e-05	6.76e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—NRAS—lung cancer	1.09e-05	6.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CXCL8—lung cancer	1.09e-05	6.75e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CDKN1A—lung cancer	1.09e-05	6.74e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTP1—lung cancer	1.08e-05	6.73e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PTEN—lung cancer	1.08e-05	6.72e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRAS—lung cancer	1.08e-05	6.71e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRAS—lung cancer	1.08e-05	6.69e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—KRAS—lung cancer	1.08e-05	6.69e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—lung cancer	1.07e-05	6.65e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—lung cancer	1.06e-05	6.56e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CAT—lung cancer	1.06e-05	6.55e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—lung cancer	1.05e-05	6.52e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CXCL8—lung cancer	1.05e-05	6.52e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.05e-05	6.51e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EP300—lung cancer	1.05e-05	6.5e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRAS—lung cancer	1.04e-05	6.47e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MAPK3—lung cancer	1.04e-05	6.47e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—lung cancer	1.04e-05	6.46e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL2—lung cancer	1.04e-05	6.45e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—IL6—lung cancer	1.03e-05	6.42e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EP300—lung cancer	1.03e-05	6.41e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—IL6—lung cancer	1.03e-05	6.41e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCB1—lung cancer	1.03e-05	6.37e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—lung cancer	1.02e-05	6.32e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.02e-05	6.3e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—lung cancer	1.01e-05	6.3e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MYC—lung cancer	1.01e-05	6.29e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCND1—lung cancer	1.01e-05	6.29e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JUN—lung cancer	1.01e-05	6.28e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TYMS—lung cancer	1.01e-05	6.26e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—lung cancer	1.01e-05	6.24e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—lung cancer	1.01e-05	6.24e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL2—lung cancer	1e-05	6.23e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—NQO1—lung cancer	1e-05	6.23e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—IL6—lung cancer	9.99e-06	6.2e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GSTM1—lung cancer	9.97e-06	6.18e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—lung cancer	9.92e-06	6.15e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EGFR—lung cancer	9.92e-06	6.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	9.9e-06	6.14e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MDM2—lung cancer	9.86e-06	6.12e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—lung cancer	9.84e-06	6.11e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RAF1—lung cancer	9.83e-06	6.1e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STAT3—lung cancer	9.82e-06	6.09e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	9.81e-06	6.08e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NRAS—lung cancer	9.8e-06	6.08e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—lung cancer	9.79e-06	6.07e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCND1—lung cancer	9.79e-06	6.07e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PTEN—lung cancer	9.78e-06	6.07e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JUN—lung cancer	9.77e-06	6.06e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ERBB2—lung cancer	9.72e-06	6.03e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STAT3—lung cancer	9.69e-06	6.01e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NRAS—lung cancer	9.67e-06	6e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CB—lung cancer	9.6e-06	5.95e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MTOR—lung cancer	9.6e-06	5.95e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOA1—lung cancer	9.57e-06	5.94e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—lung cancer	9.55e-06	5.92e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—lung cancer	9.53e-06	5.91e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—lung cancer	9.5e-06	5.89e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDKN1A—lung cancer	9.47e-06	5.87e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP1A1—lung cancer	9.45e-06	5.86e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PTEN—lung cancer	9.45e-06	5.86e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MAPK3—lung cancer	9.38e-06	5.82e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ERCC2—lung cancer	9.37e-06	5.81e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KRAS—lung cancer	9.37e-06	5.81e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EP300—lung cancer	9.33e-06	5.79e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MAPK3—lung cancer	9.26e-06	5.74e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CXCL8—lung cancer	9.22e-06	5.72e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—lung cancer	9.21e-06	5.72e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRAS—lung cancer	9.16e-06	5.68e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MYC—lung cancer	9.13e-06	5.66e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—lung cancer	9.07e-06	5.63e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—STK11—lung cancer	9.05e-06	5.61e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EP300—lung cancer	9.01e-06	5.59e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MYC—lung cancer	9.01e-06	5.59e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EGFR—lung cancer	8.93e-06	5.54e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—lung cancer	8.91e-06	5.53e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—lung cancer	8.84e-06	5.48e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—lung cancer	8.83e-06	5.48e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL2—lung cancer	8.81e-06	5.47e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EGFR—lung cancer	8.81e-06	5.47e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—IL6—lung cancer	8.77e-06	5.44e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—lung cancer	8.76e-06	5.43e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STAT3—lung cancer	8.75e-06	5.43e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CG—lung cancer	8.74e-06	5.42e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NRAS—lung cancer	8.73e-06	5.42e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PIK3CA—lung cancer	8.61e-06	5.34e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCND1—lung cancer	8.59e-06	5.33e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JUN—lung cancer	8.57e-06	5.32e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—lung cancer	8.53e-06	5.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STAT3—lung cancer	8.45e-06	5.24e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KRAS—lung cancer	8.43e-06	5.23e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NRAS—lung cancer	8.43e-06	5.23e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTP1—lung cancer	8.37e-06	5.19e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MAPK3—lung cancer	8.36e-06	5.19e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—lung cancer	8.34e-06	5.17e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TP53—lung cancer	8.33e-06	5.17e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KRAS—lung cancer	8.32e-06	5.16e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—POMC—lung cancer	8.32e-06	5.16e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDKN1A—lung cancer	8.31e-06	5.16e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PTEN—lung cancer	8.29e-06	5.14e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CAT—lung cancer	8.15e-06	5.05e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MYC—lung cancer	8.13e-06	5.04e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOA1—lung cancer	8.11e-06	5.03e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CREBBP—lung cancer	8.1e-06	5.03e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—lung cancer	8.09e-06	5.02e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MAPK3—lung cancer	8.07e-06	5.01e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRAS—lung cancer	7.96e-06	4.94e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EGFR—lung cancer	7.95e-06	4.93e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCB1—lung cancer	7.92e-06	4.92e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EP300—lung cancer	7.91e-06	4.91e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MYC—lung cancer	7.85e-06	4.87e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TYMS—lung cancer	7.78e-06	4.83e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.76e-06	4.82e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PIK3CA—lung cancer	7.75e-06	4.81e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GSTM1—lung cancer	7.69e-06	4.77e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—lung cancer	7.69e-06	4.77e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CD—lung cancer	7.68e-06	4.77e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EGFR—lung cancer	7.68e-06	4.76e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PIK3CA—lung cancer	7.65e-06	4.74e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6—lung cancer	7.62e-06	4.73e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—lung cancer	7.58e-06	4.7e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KRAS—lung cancer	7.51e-06	4.66e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TP53—lung cancer	7.5e-06	4.65e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—lung cancer	7.49e-06	4.65e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STAT3—lung cancer	7.42e-06	4.6e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CG—lung cancer	7.4e-06	4.59e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NRAS—lung cancer	7.4e-06	4.59e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TP53—lung cancer	7.4e-06	4.59e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP1A1—lung cancer	7.29e-06	4.52e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KRAS—lung cancer	7.25e-06	4.5e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ERCC2—lung cancer	7.23e-06	4.49e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRAS—lung cancer	7.17e-06	4.45e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MAPK3—lung cancer	7.09e-06	4.4e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRAS—lung cancer	7.07e-06	4.39e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—POMC—lung cancer	7.05e-06	4.37e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—lung cancer	7.03e-06	4.36e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	6.9e-06	4.28e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MYC—lung cancer	6.89e-06	4.28e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CREBBP—lung cancer	6.86e-06	4.26e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6—lung cancer	6.86e-06	4.26e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6—lung cancer	6.77e-06	4.2e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EGFR—lung cancer	6.74e-06	4.18e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CB—lung cancer	6.69e-06	4.15e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TP53—lung cancer	6.68e-06	4.14e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	6.66e-06	4.13e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—lung cancer	6.63e-06	4.12e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CD—lung cancer	6.51e-06	4.04e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TP53—lung cancer	6.45e-06	4e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—lung cancer	6.42e-06	3.99e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRAS—lung cancer	6.39e-06	3.96e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KRAS—lung cancer	6.37e-06	3.95e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—lung cancer	6.33e-06	3.93e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOA1—lung cancer	6.26e-06	3.88e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—lung cancer	6.25e-06	3.87e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRAS—lung cancer	6.16e-06	3.82e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6—lung cancer	6.11e-06	3.79e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6—lung cancer	5.9e-06	3.66e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PIK3CA—lung cancer	5.85e-06	3.63e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTEN—lung cancer	5.79e-06	3.59e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CG—lung cancer	5.71e-06	3.54e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CB—lung cancer	5.67e-06	3.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TP53—lung cancer	5.66e-06	3.51e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—lung cancer	5.64e-06	3.5e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—lung cancer	5.62e-06	3.49e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—EP300—lung cancer	5.52e-06	3.42e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—lung cancer	5.44e-06	3.38e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—POMC—lung cancer	5.44e-06	3.37e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRAS—lung cancer	5.41e-06	3.36e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CREBBP—lung cancer	5.3e-06	3.29e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6—lung cancer	5.18e-06	3.21e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CD—lung cancer	5.02e-06	3.12e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—lung cancer	4.96e-06	3.08e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTEN—lung cancer	4.9e-06	3.04e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—lung cancer	4.78e-06	2.96e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—EP300—lung cancer	4.67e-06	2.9e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CB—lung cancer	4.38e-06	2.72e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—lung cancer	4.34e-06	2.69e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PIK3CA—lung cancer	4.08e-06	2.53e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTEN—lung cancer	3.78e-06	2.35e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—EP300—lung cancer	3.61e-06	2.24e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PIK3CA—lung cancer	3.46e-06	2.14e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—lung cancer	3.33e-06	2.07e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—lung cancer	2.82e-06	1.75e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PIK3CA—lung cancer	2.67e-06	1.66e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—lung cancer	2.18e-06	1.35e-05	CbGpPWpGaD
